Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Acylated and unacylated ghrelin dosages1件: Lenomorelin---3件: 193, 201, 202 💬
2CC----13件: 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 💬
3DTR Melatonin (NIH CC PDS)1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
4Ghrelin1件: Lenomorelin---6件: 6, 78, 193, 201, 202, 299 💬
5Hourly dosing of the nychtemeral secretion of melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
6Melatonin1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬
7Melatonin CR1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬
8RM-493----2件: 193, 202 💬
9Setmelanotide1件: Setmelanotide1件: Setmelanotide 💬 1件: MC4R 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 202, 265 💬
10Tasimelteon1件: Tasimelteon1件: Tasimelteon 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202 💬